Form 4 for RNXT RenovoRx, Inc.

Accepted 2026-09-15 06:04:14 ET · period of report 2026-09-10 · accession 0001493152-26-042650 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2026-09-15 06:04	2026-09-10	RNXT	VOLL MARK	CFO	A - Grant	$0.00	+80.0K	222.4K	+56%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-09-10	A	A	80,000	$0.00	222,380	D	—	—	(F1) The reported transaction involved the Reporting Person's receipt of a grant of 80,000 restricted stock units ("RSUs") for his future service as the Chief Financial Officer of the Issuer, subject to monthly vesting with the RSUs valued based on the closing price on the last trading day of the month in which the services were performed. (F1) The reported transaction involved the Reporting Person's receipt of a grant of 80,000 restricted stock units ("RSUs") for his future service as the Chief Financial Officer of the Issuer, subject to monthly vesting with the RSUs valued based on the closing price on the last trading day of the month in which the services were performed. (F1) The reported transaction involved the Reporting Person's receipt of a grant of 80,000 restricted stock units ("RSUs") for his future service as the Chief Financial Officer of the Issuer, subject to monthly vesting with the RSUs valued based on the closing price on the last trading day of the month in which the services were performed.